Kinetics and computational study of butyrylcholinesterase inhibition by methylrosmarinate: relevance to Alzheimer’s disease treatment

MLA

Sani Muhammad Uzairu, et al. “Kinetics and Computational Study of Butyrylcholinesterase Inhibition by Methylrosmarinate: Relevance to Alzheimer’s Disease Treatment.” Heliyon, vol. 8, no. 9, Sept. 2022. EBSCOhost, https://doi.org/10.1016/j.heliyon.2022.e10613.

APA

Sani Muhammad Uzairu, Yahaya Tijani, Madu Adamu Gadaka, Babagana Modu, Miriam Watafua, Hadiza Ali Ahmad, Umar Abdullahi Zakariya, Aminu Ibrahim, Aliyu Daja, Hassan Zanna, & Abdullahi Balarabe Sallau. (2022). Kinetics and computational study of butyrylcholinesterase inhibition by methylrosmarinate: relevance to Alzheimer’s disease treatment. Heliyon, 8(9). https://doi.org/10.1016/j.heliyon.2022.e10613

Chicago

Sani Muhammad Uzairu, Yahaya Tijani, Madu Adamu Gadaka, Babagana Modu, Miriam Watafua, Hadiza Ali Ahmad, Umar Abdullahi Zakariya, et al. 2022. “Kinetics and Computational Study of Butyrylcholinesterase Inhibition by Methylrosmarinate: Relevance to Alzheimer’s Disease Treatment.” Heliyon 8 (9). doi:10.1016/j.heliyon.2022.e10613.